• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Blinatumomab
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    partial basket chart

    Monoclonal Antibody. Blinatumomab 12.5 mcg/ml.
    VIAL(concent. for sol. for infus.+ stabilizer sol. for infus.): 1×35mcg. Recommended dose (for adult patients at least 45 kg in weight): 1st Cycle Start. dose Days 1 – 7: 9 mcg/d via cont. infusSubseq. dose Days 8  28: 28 mcg/d via cont. infus. 2 week-tmt. free interval (Days 29  42)2nd cycle & subseq. cycles (Days 1 – 28): 28 mcg/d via cont. infus. See lit.
    Tmt. of adult pt. with Philadelphia chromosome-negat. relapsed/ refract.B‑cell precursor ALL. Limitations of use: After fail. of two previous tmts. and with no CNS involvem.
    C/I: Hyperses, lact.